TX-based Merit Medicine secures $2million in seed funding. Lead the funding round was LiveOak Ventures. The money will be used by the business to increase operations and development initiatives.
Read also – NC-based Areteia Therapeutics Secures Additional $75Million in Series A Round Funding
Merit Medicine is a health tech firm led by Founder and CEO Ali Panjwani. It uses cutting edge AI insights to assist self-funded employers in anticipating high-cost medical expenses, specialty prescription consumption, and chronic, difficult, and uncommon illnesses.
Benefits executives are empowered with AI-powered forecasts, which facilitate more efficient budgeting and guarantee the best healthcare possible for each employee. Across the country, the company employs remote workers.
Read also – WA-based Vimly Benefit Solutions Secures an Investment
About Merit Medicine
Innovative health tech startup Merit Medicine uses cutting-edge AI to lower the uncertainty associated with large expenditures for small risk-bearing organizations and self-funded businesses.
Read also – CA-based PatientFi Secures Growth Equity Investment from Questa Capital
To enhance patient access to timely and economical care for chronic, complex, and rare diseases, they hope to forecast catastrophic events that may arise from expensive medical and specialized pharmacological therapies.
